NS 050
Alternative Names: NS-050Latest Information Update: 24 Jan 2025
Price :
$50 *
At a glance
- Originator NeuShen Therapeutics
- Class Antidementias; Antiparkinsonians
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alzheimer's disease; Parkinson's disease
Most Recent Events
- 08 Jan 2025 Early research in Alzheimer's disease in China (unspecified route) before January 2025 (NeuShen Therapeutics pipeline, January 2025)
- 08 Jan 2025 Early research in Parkinson's disease in China (unspecified route) before January 2025 (NeuShen Therapeutics pipeline, January 2025)